Liquid Biopsy Market is Anticipated To Grow USD 17,372.28 Mn by 2022; Assert MRFR


Free Press Release DB | Press Release Date : Jan 25, 2018  Download


Global Liquid Biopsy Market Information, by Biomarker Types, Circulating Tumor Dna, Extracellular Vesicles (Evs) and Other Biomarker, by Application, by Sample And End User - Forecast to 2022


The Global Liquid Biopsy Market is To Hike $ 3950 Million and will reach $ 17,372.28 Million growing at a CAGR of 28%.

Biopsy involves extracting a sample of tissue and testing it for the presence of diseases especially cancer. Traditional tissue biopsy is a painful technique and also has a high rate of false results. Moreover the technique is costly, time consuming and not applicable for extracting samples such as those close to vital organs such as heart. Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of sophisticated detectors with extremely low detection rates have enabled the early detection of diseases which is the holy grail of cancer.

A liquid biopsy is a largely non-invasive, sampling and analysis of liquid state biological tissue for diagnostic and monitoring diseases such as cancer. Liquid biopsy is the direct clinical application of two advances in medical science namely human genome sequencing and rising sensitivity of detecting techniques and assays.

Other market drivers for the liquid biopsy market are rising rates of cancer, growing investment in research and development, collaborations between companies and public organizations, rise in geriatric population, rising expenditure on health etc. The factors which are inhibiting the growth of the market includes the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. However, not all cancer patients benefit from early detection as some cancer types such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample-request/710

Key findings

Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48% of the revenue share of the liquid biopsy market.On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period

Key Players for Global Liquid Biopsy market:

The major participants of this market are: Guardant Health, Inc., Trovagene, Inc., RainDance Technologies, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics, Inivata Ltd., SAGA Diagnostics AB, Exosome Diagnostics and others.

Segments:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/710

Regional Analysis of Global Liquid Biopsy market:

Globally North America is the largest market for Global Liquid Biopsy market. Europe is the second-largest market for Global Liquid Biopsy market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future. North America accounted for the largest market share of 37.95% in 2016 accounting for a market value of 1,499.10 million in  2016. Asia pacific is the fastest growing market which is growing at a CAGR of 28.8%.

Continue…

We are thankful for the support and assistance from Global Liquid Biopsy Market Research Report- Forecast to 2022 chain related technical experts and marketing experts during Research Team survey and interviews.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.




Contact Person & Company

Name

:

Rahul Pise

Company

:

Market Research Future

Contact Numbers

Telephone No.

:

Fax No.

:

Handphone No.

:

Website

Website 1

:

Website 2

:

Youtube

:

PR Tags

:

Liquid Biopsy Market, Liquid Biopsy Market Growth, Liquid Biopsy Market Forecast, Liquid Biopsy, Liquid Biopsy Market Analysis, Liquid Biopsy Market Share, Liquid Biopsy Market Outlook, Marketresearchfuture.com,

Address


Contact The Author



Contact Rahul Pise






More Press Release From Author



Hepatitis C Drugs Market: Industry Trend, Demand, Growth & Global Forecast to 2022


Free Press Release DB :

Market Research Future published a research report on “Global Hepatitis C Drugs Market Research Report- Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. --> Read This Press Release !



By : Rahul, Pise ( Feb 1, 2018 )
Category : Business Press Release | Country : India Press Release




Intraoperative Neurophysiological Monitoring Market Outlook and Worldwide Forecast to 2027


Free Press Release DB :

Intraoperative Neurophysiological Monitoring Market Information, by type (EEG, EMG, Evoked Potential (EP)) by Method (Invasive, Non-Invasive, Minimally Invasive) by Source (In-house, Outsource, Tele-Health), by Procedure – Global Forecast to 2027 --> Read This Press Release !



By : Rahul, Pise ( Jan 25, 2018 )
Category : Business Press Release | Country : India Press Release




Dental Suture Market: Huge Growth USD 779.1 Mn by 2027; Declare MRFR


Free Press Release DB :

Market Research Future published a cooked research report on “Global Dental Suture Market Research Report - Forecast to 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. --> Read This Press Release !



By : Rahul, Pise ( Jan 25, 2018 )
Category : Business Press Release | Country : India Press Release





Read More Articles From Rahul Pise



Disclaimer

The author of the press releases are solely responsible for the content of their press releases. Freepressreleasedb.com can't be held liable for the content posted by author. Please check the accuracy of the press release before using the press release. If necessary please contact the author. Thank you.




Report Abuse